![]()
|
|
||||||||
(Received for publication, June 12, 1997)
From the Elongin C is a 112-amino acid protein that is
found in mammalian cells as a positive regulatory subunit of
heterotrimeric RNA polymerase II elongation factor Elongin (SIII) and
as a component of a multiprotein complex containing the von
Hippel-Lindau (VHL) tumor suppressor protein. As a subunit of the
Elongin complex, Elongin C interacts directly with the
transcriptionally active Elongin A subunit and potently induces its
elongation activity; in addition, Elongin C interacts with the
ubiquitin-like Elongin B subunit, which regulates the interaction of
Elongin C with Elongin A. As a component of the VHL complex, Elongin C
interacts directly with both Elongin B and the VHL protein. Binding of
the VHL protein to Elongin C was found to prevent Elongin C from
interacting with and activating Elongin A in vitro, leading
to the proposal that one function of the VHL protein may be to regulate
RNA polymerase II elongation by negatively regulating the Elongin
complex. In this report, we identify Elongin C sequences required for
its interaction with the VHL protein. We previously demonstrated that the ability of Elongin C to bind and activate Elongin A is sensitive to
mutations in the C-terminal half of Elongin C, as well as to mutations
in an N-terminal Elongin C region needed for formation of the Elongin
BC complex. Here we show that interaction of Elongin C with the VHL
tumor suppressor protein depends strongly on sequences in the C
terminus of Elongin C but is independent of the N-terminal Elongin C
region required for binding to Elongin B and for binding and activation
of Elongin A. Taken together, our results are consistent with the
proposal that the VHL protein negatively regulates Elongin C activation
of the Elongin complex by sterically blocking the interaction of
C-terminal Elongin C sequences with Elongin A. In addition, our finding
that only a subset of Elongin C sequences required for its interaction
with Elongin A are critical for binding to VHL may offer the
opportunity to develop reagents that selectively interfere with Elongin
and VHL function.
Volume 272, Number 43,
Issue of October 24, 1997
pp. 27444-27449
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Identification of Elongin C Sequences Required for Interaction
with the von Hippel-Lindau Tumor Suppressor Protein
§
,
and
§
Program in Molecular and Cell Biology,
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, the § Department of Biochemistry and Molecular Biology,
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
73190, and the ¶ Cell Biology and Metabolism Branch, NICHD,
National Institutes of Health, Bethesda, Maryland 20892
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Blanchette, C. Y. Cheng, Q. Yan, G. Ketner, D. A. Ornelles, T. Dobner, R. C. Conaway, J. W. Conaway, and P. E. Branton Both BC-Box Motifs of Adenovirus Protein E4orf6 Are Required To Efficiently Assemble an E3 Ligase Complex That Degrades p53 Mol. Cell. Biol., November 1, 2004; 24(21): 9619 - 9629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kroll, W. R. Paulding, P. O. Schnell, M. C. Barton, J.W. Conaway, R. C. Conaway, and M. F. Czyzyk-Krzeska von Hippel-Lindau Protein Induces Hypoxia-regulated Arrest of Tyrosine Hydroxylase Transcript Elongation in Pheochromocytoma Cells J. Biol. Chem., October 15, 1999; 274(42): 30109 - 30114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pause, B. Peterson, G. Schaffar, R. Stearman, and R. D. Klausner Studying interactions of four proteins in the yeast two-hybrid system: Structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein PNAS, August 17, 1999; 96(17): 9533 - 9538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lisztwan, G. Imbert, C. Wirbelauer, M. Gstaiger, and W. Krek The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity Genes & Dev., July 15, 1999; 13(14): 1822 - 1833. [Abstract] [Full Text] |
||||
![]() |
C. E. Stebbins, W. G. Kaelin Jr., and N. P. Pavletich Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function Science, April 16, 1999; 284(5413): 455 - 461. [Abstract] [Full Text] |
||||
![]() |
T. Kamura, S. Sato, D. Haque, L. Liu, W. G. Kaelin Jr., R. C. Conaway, and J. W. Conaway The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families Genes & Dev., December 15, 1998; 12(24): 3872 - 3881. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |